PARADIGM BIOCAPITAL ADVISORS LP purchased 1.5% of their position (100K shares) of OLEMA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $1.16M — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/8/2023ACC: 0001104659-23-124717
10% Owner
Since Sep 2023
+100K
Net shares
Net buyer
$1.16M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Indirect
Shares
+100K
Price / share
$11.60
Trade value
$1.16M
% of position
1.5%
12/6/2023
6.49M→6.59M
Total
Net shares
+100K
Net value
$1.16M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Indirect | 12/6/2023 | P · Purchase | +100K | $11.60 | $1.16M | 1.5% | 6.49M | 6.59M |
| Total | +100K | $1.16M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock, par value $0.0001 per share
IndirectShares owned1.31M
Total
1.31M indirect1.31M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.0001 per share | 1.31M | Indirect |
| Total | 1.31M | 1.31M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported